Edward Li takes office as Board Member at Large for HOPA

Edward Li, Pharm.D., M.P.H., BCOP, associate professor in the College of Pharmacy, was named as an At Large Member of the Board of Directors at the recent Hematology/Oncology Pharmacy Association (HOPA) annual conference, held March 16-19 in Atlanta, Georgia.

An active member of HOPA since 2009, Li recently served as Vice-Chair of the Health Policy Committee. In this role, he developed key policy statements for biosimilars and counterfeit drugs on behalf of the organization. He has also served on both the BCOP Recertification and Programming committees. In addition, Li has presented at several HOPA annual conferences, sharing his expertise in describing and evaluating cancer practice trends, economics and outcomes.

Formed in 2004, HOPA is a nonprofit professional organization that helps oncology and hematology pharmacy practitioners and associates to provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. The organization has more than 2,500 members and includes oncology pharmacists, pharmacy administrators, researchers, residents, interns and technicians specializing in hematology/oncology practice.